Compare PMN & BYRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PMN | BYRN |
|---|---|---|
| Founded | 2004 | 2005 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 115.5M | 136.3M |
| IPO Year | 2022 | 2013 |
| Metric | PMN | BYRN |
|---|---|---|
| Price | $10.53 | $5.73 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $42.67 | $23.17 |
| AVG Volume (30 Days) | 16.1K | ★ 353.6K |
| Earning Date | 05-13-2026 | 04-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.03 |
| Revenue | N/A | ★ $16,566,295.00 |
| Revenue This Year | N/A | $4.98 |
| Revenue Next Year | N/A | $16.86 |
| P/E Ratio | ★ N/A | $187.33 |
| Revenue Growth | N/A | ★ 1692.08 |
| 52 Week Low | $0.29 | $4.84 |
| 52 Week High | $27.40 | $33.44 |
| Indicator | PMN | BYRN |
|---|---|---|
| Relative Strength Index (RSI) | 51.45 | 44.72 |
| Support Level | $10.55 | $4.84 |
| Resistance Level | $11.37 | $6.68 |
| Average True Range (ATR) | 0.58 | 0.37 |
| MACD | 0.09 | -0.04 |
| Stochastic Oscillator | 74.37 | 22.41 |
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.
Byrna Technologies Inc is a designer, manufacturer, retailer, and distributor of technological solutions for security situations that do not require the use of lethal force. The company generates its revenue from the United States, South Africa, Europe, South America, Asia, and Canada.